Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Waters Corp ACQUITY UPLC TQD system receives medical device approval in China


Thursday, 5 Jun 2014 08:35am EDT 

Waters Corp:Says Chinese Food and Drug Administration (CFDA) approved the registration of the ACQUITY UPLC((reg))TQD system for legal promotion and sale in China as a medical device for routine diagnostic applications and neonatal metabolites diseases screening.A continuation of Waters commitment to China and to growing clinical LC-MS applications worldwide, this registration represents the second Waters' mass spectrometer approved for in vitro diagnostic (IVD) applications in China. 

Company Quote

107.58
3.12 +2.99%
2:43pm EDT